| Period | Weighting | Quarter | ||||||
|---|---|---|---|---|---|---|---|---|
| Company | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| GOLDMAN SACHS GROUP INC | 11 | 11 | 0.00% | 0.00% | 0.00% | Q4 2014 | Q2 2017 | 11 |
| 683 Capital Management, LLC | 10 | 10 | 1.03% | 2.74% | 6.14% | Q4 2014 | Q1 2017 | 10 |
| WELLS FARGO & COMPANY/MN | 9 | 9 | 0.00% | 0.00% | 0.00% | Q2 2015 | Q2 2017 | 9 |
| Tekla Capital Management LLC | 8 | 8 | 0.16% | 0.24% | 0.36% | Q4 2014 | Q3 2016 | 8 |
| WELLINGTON MANAGEMENT GROUP LLP | 2 | 2 | 0.00% | 0.00% | 0.00% | Q4 2014 | Q1 2015 | 2 |
| AMERIPRISE FINANCIAL INC | 2 | 2 | 0.00% | 0.00% | 0.00% | Q4 2014 | Q1 2015 | 2 |
| Perceptive Advisors | 2 | 2 | 0.42% | 0.47% | 0.52% | Q1 2015 | Q2 2015 | 2 |
| ZAZOVE ASSOCIATES LLC | 1 | 1 | 0.68% | 0.68% | 0.68% | Q4 2014 | Q4 2014 | 1 |
| Orchard Hill Capital Management LP | 1 | 1 | 13.39% | 13.39% | 13.39% | Q4 2014 | Q4 2014 | 1 |
| PIPER SANDLER & CO. | 1 | 1 | 3.52% | 3.52% | 3.52% | Q3 2015 | Q3 2015 | 1 |
This page lists all the filers that currently own SUPERNUS PHARMACEUTICALS INC or have owned SUPERNUS PHARMACEUTICALS INC in the past.